Thrombosis occurs as a result of the body's haemostatic pathway being activated inappropriately, leading to the formation of blood clots. Aspen's global basket of anticoagulant thrombosis products is aimed at the prevention and treatment of thrombotic disease, including deep vein thrombosis, pulmonary embolism and acute coronary syndrome.
Our product range includes Fraxiparine and Mono-embolex (low molecular weight he-drains) and Arixtra ( a Xa inhibitor). Organ is a heparin derivative (heparinoid) indicated for the treatment of heparin-induced thrombocytopenia ("HIT"). HIT is an adverse reaction occurring in a limited number of patients undergoing heparin-related therapy.